NEW

Private Company Data

Track valuations, funding rounds, and more before IPO.

Drug Manufacturers - Specialty & Generic
Companies engaged in development and discovery of branded forms of drug, drug-related products, generic drug products, and animal-related drugs. Also includes companies that cultivate, process, and farm cannabis or marijuana.
Market Cap
181.601B
Industry Weight
2.76%
Companies
87
Employees
129,386
Drug Manufacturers - Specialty & Generic S&P 500 ^GSPC
Advanced Chart
Loading Chart for Drug Manufacturers - Specialty & Generic

Day Return

Industry
0.39%
S&P 500
0.55%

YTD Return

Industry
7.22%
S&P 500
5.00%

1-Year Return

Industry
1.33%
S&P 500
6.80%

3-Year Return

Industry
14.54%
S&P 500
21.93%

5-Year Return

Industry
31.78%
S&P 500
117.13%

Note: Industry performance is calculated based on the previous closing price of all industry constituents

Largest Companies in This Industry

View More
Table View
Heatmap View
Name
Last Price
1Y Target Est.
Market Weight
Market Cap
Day Change %
YTD Return
Avg. Analyst Rating
164.65 199.99 41.98% 74.284B +0.94% +1.06%
Buy
131.92 132.00 7.90% 13.986B +0.08% +57.95%
Hold
308.27 396.46 7.78% 13.763B +0.42% -12.63%
Buy
110.60 164.41 6.33% 11.198B -2.26% -18.97%
Buy
8.71 12.16 5.88% 10.396B +0.35% -30.04%
Hold
97.60 134.38 3.83% 6.786B +1.50% +9.10%
Strong Buy
33.02 39.20 3.02% 5.343B -0.57% +14.81%
Buy
10.50 15.09 2.93% 5.191B +0.86% -13.29%
Buy
85.97 89.14 2.40% 4.247B +1.03% +10.09%
Buy
8.38 11.67 2.19% 3.871B +1.21% +5.81%
Buy
View More

Investing in the Drug Manufacturers - Specialty & Generic Industry

Start Investing in Drug Manufacturers - Specialty & Generic Through These Companies

Top Performing Companies

View More
Name
Last Price
1Y Target Est.
YTD Return
31.88 - +545.34%
131.92 132.00 +57.95%
5.90 9.88 +50.90%
9.17 18.00 +37.28%
11.44 - +35.38%
View More

High Growth Companies

View More
Name
Last Price
Growth Estimate
YTD Return
5.90 +457.14% +50.90%
29.85 +373.64% +4.19%
12.98 +325.00% -2.55%
33.02 +85.42% +14.81%
110.60 +62.35% -18.97%
View More

Drug Manufacturers - Specialty & Generic Research

View More

Discover the Latest Analyst and Technical Research for This Industry

  • ANIP: Raising target price to $70.00

    ANI PHARMACEUTICALS INC has an Investment Rating of HOLD; a target price of $70.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
    Argus• 5 days ago
     

  • COLL: Raising target price to $32.00

    COLLEGIUM PHARMACEUTICAL INC has an Investment Rating of HOLD; a target price of $32.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.

    Rating
    Price Target
    Argus• 5 days ago
     

  • SUPN: Raising target price to $35.00

    SUPERNUS PHARMACEUTICALS INC has an Investment Rating of HOLD; a target price of $35.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
    Argus• 5 days ago
     

  • AMPH: Raising target price to $31.00

    AMPHASTAR PHARMACEUTICALS IN has an Investment Rating of BUY; a target price of $31.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.

    Rating
    Price Target
    Argus• 5 days ago
     
View More

From the Community

Drug Manufacturers - Specialty & Generic News